IRCT20090117001556N144RecruitingPhase 2
Evaluating the effect of sulforaphane supplementation in women with Polycystic ovary syndrome (PCOS) on depression, insulin resistance, and lipid profile change
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 40 years (—)
- Sex
- Female
Inclusion Criteria
- •Diagnosis of PCOS according to Rotterdam
- •Mild to moderate depression
- •18-40 years old
- •BMI = or > 25
- •High blood fat
- •Disruption of Glucose tolerance test
Exclusion Criteria
- •Lactation or gestation
- •Metabolic or thyroid dysfunction
- •Hyperprolactinemia
- •Hypercortisolemia
- •Severe depression
- •CNS drugs used such as antidepressants or anxiolytics
- •Insulin administration
- •Uncontrolled blood glucose level
- •Intense physical activity
- •History of severe stress
- •Emotional failure or hospitalization in recent past
- •History of mental health problems in first-degree relatives
Investigators
Similar Trials
Completed
Not Applicable
Effects of oral consumption of sulforaphane precursor-rich broccoli supersprouts on serum levels of advanced glycation end products in humanshealthy humansJPRN-UMIN000018342Kurume University School of Medicine25
Recruiting
Not Applicable
Investigation of the effect of saffron on asthmaModerate persistent allergic asthma.Moderate persistent allergic asthmaIRCT20180418039354N1Ahvaz University of Medical Sciences76
Not yet recruiting
Phase 3
The effect of saffron supplementation on Parkinson's diseaseParkinson's diseaseIRCT20121216011763N61Esfahan University of Medical Sciences86
Completed
Not Applicable
Study on the absorption of sulforaphaneHealthy adultsJPRN-UMIN000023134Innovation Division, Kagome Co., Ltd.20
Completed
Not Applicable
Study on the absorption of sulforaphane after ingesting vegetable materialsHealthy adultsJPRN-UMIN000039385Innovation Division, Kagome Co., Ltd.15